We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
PUT
SLB Ltd
SLB
$79.7B
| $9.7M | 0.01% |
252,800
+120,100
| +91% | +$4.35M |
|
1002
PUT
Constellation Brands
STZ
$22.9B
| $9.66M | 0.01% |
70,000
-10,500
| -13% | -$1.44M |
|
1003
Archer Aviation
ACHR
$5.18B
| $9.6M | 0.01% |
+1,276,177
| New | +$12M |
|
|
ALEX
1004
DELISTED
Alexander & Baldwin
ALEX
| $9.58M | 0.01% |
+464,093
| New | +$8.06M |
|
1005
CALL
First Horizon
FHN
$12B
| $9.56M | 0.01% |
+400,000
| New | +$8.92M |
|
1006
Ionis Pharmaceuticals
IONS
$9.21B
| $9.54M | 0.01% |
120,577
-639,534
| -84% | -$48.2M |
|
1007
PUT
United Airlines
UAL
$41B
| $9.52M | 0.01% |
85,100
+39,700
| +87% | +$4.01M |
|
1008
GDS Holdings
GDS
$6.54B
| $9.43M | 0.01% |
270,069
-20,981
| -7% | -$725K |
|
1009
Invivyd
IVVD
$203M
| $9.4M | 0.01% |
+3,806,976
| New | +$7.92M |
|
1010
Silgan Holdings
SLGN
$4.35B
| $9.4M | 0.01% |
232,826
-216,935
| -48% | -$8.8M |
|
1011
Garrett Motion
GTX
$5.43B
| $9.39M | 0.01% |
538,713
+492,813
| +1,074% | +$7.85M |
|
1012
Lantheus
LNTH
$6.57B
| $9.37M | 0.01% |
140,781
+112,157
| +392% | +$6.53M |
|
1013
PUT
KLA
KLAC
$262B
| $9.36M | 0.01% |
77,000
-66,000
| -46% | -$7.74M |
|
1014
Clear Secure
YOU
$4.97B
| $9.33M | 0.01% |
265,887
+153,728
| +137% | +$5.24M |
|
1015
CALL
Biogen
BIIB
$30.1B
| $9.31M | 0.01% |
52,900
+48,000
| +980% | +$7.84M |
|
1016
Ocular Therapeutix
OCUL
$2.14B
| $9.27M | 0.01% |
763,559
-1,425,717
| -65% | -$17.3M |
|
1017
CALL
Regeneron Pharmaceuticals
REGN
$82.1B
| $9.26M | 0.01% |
12,000
+4,600
| +62% | +$3.12M |
|
1018
HEICO Corp Class A
HEI.A
$37B
| $9.24M | 0.01% |
+36,622
| New | +$9.05M |
|
1019
PUT
Albemarle
ALB
$15.3B
| $9.22M | 0.01% |
65,200
-4,400
| -6% | -$499K |
|
1020
Kyverna Therapeutics
KYTX
$488M
| $9.22M | 0.01% |
+980,869
| New | +$7.28M |
|
|
DENN
1021
DELISTED
Denny's
DENN
| $9.19M | 0.01% |
+1,477,067
| New | +$8.37M |
|
1022
Hertz
HTZ
$873M
| $9.18M | 0.01% |
1,786,675
+1,523,360
| +579% | +$8.32M |
|
1023
CALL
Affirm
AFRM
$25.7B
| $9.14M | 0.01% |
122,800
-103,100
| -46% | -$7.42M |
|
1024
CALL
Rocket Companies
RKT
$40.5B
| $9.09M | 0.01% |
469,400
-54,900
| -10% | -$982K |
|
1025
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $9.03M | 0.01% |
58,200
+19,800
| +52% | +$3.05M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.